Background Background Controversy remains as
Controversy remains as to whether cannabis acts as a causal risk to whether cannabis acts as a causal risk factor for schizophrenia or other factor for schizophrenia or other functional psychotic illnesses. functional psychotic illnesses.
Aims Aims To examine critically the evidence
To examine critically the evidence that cannabis causes psychosis using that cannabis causes psychosis using established criteria of causality. established criteria of causality.
Method Method We identified five studies that
We identified five studies that included a well-defined sample drawn included a well-defined sample drawn from population-based registers or from population-based registers or cohorts and used prospective measures of cohorts and used prospective measures of cannabis use and adult psychosis. cannabis use and adult psychosis.
Results

Results On an individuallevel, cannabis
On an individuallevel, cannabis use confers an overall twofold increase in use confers an overall twofold increase in the relative risk for later schizophrenia. At the relative risk for later schizophrenia. At the population level, elimination of the population level, elimination of cannabis use wouldreducetheincidence of cannabis use wouldreduce theincidence of schizophrenia by approximately 8%, schizophrenia by approximately 8%, assuming a causal relationship.Cannabis assuming a causal relationship.Cannabis use appears to be neither a sufficient nor a use appears to be neither a sufficient nor a necessary cause for psychosis.It is a necessary cause for psychosis.It is a component cause, part of a complex component cause, part of a complex constellation of factors leading to constellation of factors leading to psychosis. psychosis.
Conclusions Conclusions Cases of psychotic
Cases of psychotic disorder could be prevented by disorder could be prevented by discouraging cannabis use among discouraging cannabis use among vulnerable youths.Research is needed to vulnerable youths.Research is needed to understand the mechanisms by which understand the mechanisms by which cannabis causes psychosis. cannabis causes psychosis. There is little dispute that cannabis intoxiThere is little dispute that cannabis intoxication can lead to acute transient psychotic cation can lead to acute transient psychotic episodes in some individuals (D'Souza episodes in some individuals (D'Souza et al et al, , 2004) and that it can produce short-term 2004) and that it can produce short-term exacerbation or recurrences of pre-existing exacerbation or recurrences of pre-existing psychotic symptoms (Thornicroft, 1990; psychotic symptoms (Thornicroft, 1990; Mathers & Ghodse, 1992; Hall & Mathers & Ghodse, 1992; Hall & Degenhardt, 2004) . However, controversy Degenhardt, 2004) . However, controversy remains about whether cannabis use can remains about whether cannabis use can actually cause schizophrenia or other actually cause schizophrenia or other functional psychotic illness in the long term functional psychotic illness in the long term (Johns, 2001) . A previous review paper, (Johns, 2001) . A previous review paper, published more than a decade ago, reached published more than a decade ago, reached no firm conclusion regarding causality and no firm conclusion regarding causality and stressed the importance of prospective stressed the importance of prospective longitudinal population-based cohort longitudinal population-based cohort studies to elucidate a possible causal assostudies to elucidate a possible causal association (Thornicroft, 1990) . Sixteen years ciation (Thornicroft, 1990) . Sixteen years after the publication of the first evidence after the publication of the first evidence that cannabis may be a causal risk factor that cannabis may be a causal risk factor for later schizophrenia (Andreasson for later schizophrenia (Andréasson et al et al, , 1988) , four recent prospective epidemio-1988), four recent prospective epidemiological studies have provided further evilogical studies have provided further evidence. We review the evidence from these dence. We review the evidence from these studies within the framework of established studies within the framework of established criteria for determining causality. criteria for determining causality.
Declaration of interest
METHOD METHOD What is a cause? What is a cause?
The precise definition of what constitutes a The precise definition of what constitutes a cause, and the elaboration of criteria for cause, and the elaboration of criteria for determining causality, have a long and determining causality, have a long and contentious history. Causal criteria that contentious history. Causal criteria that deal with the exposure-disease relationship deal with the exposure-disease relationship are often used as general guidelines for are often used as general guidelines for ascertaining causes. Hill (1965) listed the ascertaining causes. Hill (1965) listed the following criteria: strength, consistency, following criteria: strength, consistency, specificity, biological gradient, temporality, specificity, biological gradient, temporality, coherence and plausibility. Support for each coherence and plausibility. Support for each criterion strengthens the case for a causal criterion strengthens the case for a causal association but, as Rothman & Greenland association but, as point out, only one criterion, (1998) point out, only one criterion, temporality, is a temporality, is a sine qua non sine qua non for causality. for causality. Susser (1991) subsequently used the Hill Susser (1991) subsequently used the Hill criteria to distill three properties that may criteria to distill three properties that may serve to define causes: association, temporal serve to define causes: association, temporal priority and direction. priority and direction.
Association is the requirement that a Association is the requirement that a cause and an outcome appear together. cause and an outcome appear together. When the putative cause is present, the outWhen the putative cause is present, the outcome rate is higher than when the putative come rate is higher than when the putative cause is absent. There is no requirement for cause is absent. There is no requirement for the putative cause to be present in every the putative cause to be present in every case of the outcome, just that the rate of case of the outcome, just that the rate of outcome is higher in those with it than outcome is higher in those with it than without it. Temporal priority is the fundawithout it. Temporal priority is the fundamental property that the putative cause be mental property that the putative cause be present before the outcome. Direction present before the outcome. Direction refers to the fact that changes in the putarefers to the fact that changes in the putative cause will actually lead to a change in tive cause will actually lead to a change in the outcome. In other words, the associathe outcome. In other words, the association of the putative cause with the outcome tion of the putative cause with the outcome does not derive from a third factor assodoes not derive from a third factor associated with both. Epidemiologists refer to ciated with both. Epidemiologists refer to the latter phenomenon as 'confounding'. the latter phenomenon as 'confounding'.
We examine the empirical evidence put We examine the empirical evidence put forward to support the claim that cannabis forward to support the claim that cannabis is a causal factor in schizophrenia under is a causal factor in schizophrenia under these headings. these headings.
RESULTS RESULTS
Evidence for association Evidence for association
Cross-sectional national surveys (from the Cross-sectional national surveys (from the USA, Australia and The Netherlands) have USA, Australia and The Netherlands) have found that rates of cannabis use are higher found that rates of cannabis use are higher (approximately twice as high) among (approximately twice as high) among people with schizophrenia than among the people with schizophrenia than among the general population (Regier general population (Regier et al et al, 1990; Tien , 1990; Tien & Anthony, 1990; & Anthony, 1990; Hall & Degenhardt, 2000; van Os Hall & Degenhardt, 2000; van Os et al et al, , 2002 van Os et al et al, , ). 2002 .
Local surveys have also found higher Local surveys have also found higher rates of cannabis use among patients with rates of cannabis use among patients with psychosis than among community controls. psychosis than among community controls. Surveys Surveys of patients with psychotic illnesses of patients with psychotic illnesses from London have found that between 20 from London have found that between 20 and 40% report lifetime cannabis use and 40% report lifetime cannabis use (Menezes (Menezes et al et al, 1996; Grech , 1996; Grech et al et al, 1998; Duke Duke et al et al, 2001 ). Even higher rates of life-, 2001). Even higher rates of lifetime use of cannabis (51%) have been time use of cannabis (51%) have been reported among patients detained under reported among patients detained under the 1983 Mental Health Act (Wheatley, the 1983 Mental Health Act (Wheatley, 1998) . Rates are lower in rural areas: 7% 1998). Rates are lower in rural areas: 7% of patients with schizophrenia in Dumfries of patients with schizophrenia in Dumfries and Galloway, Scotland, reported proband Galloway, Scotland, reported problematic use of a drug, with 4% related lematic use of a drug, with 4% related specifically to cannabis use (McCreadie, specifically to cannabis use (McCreadie, 2002) . However, irrespective of the setting 2002). However, irrespective of the setting of the study, rates of cannabis use seem to of the study, rates of cannabis use seem to be about twice as high among patients with be about twice as high among patients with psychosis than among controls (Grech psychosis than among controls (Grech et al et al, , 1998; McCreadie, 2002) . These elevated 1998; McCreadie, 2002) . These elevated rates of cannabis use among people with rates of cannabis use among people with 11 0 11 0
( 2 0 0 4 ) , 1 8 4 , 11 0^11 7 Hambrecht & Hafner (1996) reported on a retrospective study (1996) reported on a retrospective study of 232 patients with schizophrenia. Data of 232 patients with schizophrenia. Data showed that one-third of the sample had showed that one-third of the sample had used drugs at least 1 year before onset of used drugs at least 1 year before onset of the illness, another one-third had used the illness, another one-third had used drugs and subsequently developed the illdrugs and subsequently developed the illness within a year and the remaining oneness within a year and the remaining onethird had started using cannabis after the third had started using cannabis after the occurrence of schizophrenia symptoms. In occurrence of schizophrenia symptoms. In a second study, Cantwell a second study, Cantwell et al et al (1999) (1999) investigated a group of 168 patients with investigated a group of 168 patients with first-episode schizophrenia and found that first-episode schizophrenia and found that 37% showed evidence of substance use 37% showed evidence of substance use and alcohol use before their presentation and alcohol use before their presentation to services. to services.
However, studies based on retroHowever, studies based on retrospective self-reports are prone to recall spective self-reports are prone to recall bias. To establish temporal priority (and bias. To establish temporal priority (and hence causality) we need to examine prohence causality) we need to examine prospective reports of cannabis use collected spective reports of cannabis use collected before the onset of schizophrenia, and before the onset of schizophrenia, and therefore unbiased by later outcome. therefore unbiased by later outcome. Ideally, we should also study populationIdeally, we should also study populationbased samples. based samples.
Evidence for temporal priority Evidence for temporal priority and direction and direction
We included in this core section of the We included in this core section of the review those studies that fulfilled the folreview those studies that fulfilled the following criteria: inclusion of a well-defined lowing criteria: inclusion of a well-defined sample of cases drawn from populationsample of cases drawn from populationbased registers or cohorts; use of prospectbased registers or cohorts; use of prospectively measured data on cannabis use and ively measured data on cannabis use and adult psychosis; and presentation of odds adult psychosis; and presentation of odds ratios as an indicator of the strength of ratios as an indicator of the strength of association between cannabis and later psyassociation between cannabis and later psychosis, to allow calculation of an overall chosis, to allow calculation of an overall risk estimate of cannabis use for later risk estimate of cannabis use for later psychosis. The research strategies used psychosis. The research strategies used were: computerised Medline and PsycLIT were: computerised Medline and PsycLIT searches; cross-referencing of original searches; cross-referencing of original studies; and contact with other researchers studies; and contact with other researchers in the field. in the field.
At the time of the search, five studies At the time of the search, five studies based on four samples (three cohort studies based on four samples (three cohort studies and one longitudinal population-based and one longitudinal population-based survey) fulfilled those criteria. These studies survey) fulfilled those criteria. These studies are reviewed in detail below and are sumare reviewed in detail below and are summarised in Table 1 . We used the evidence marised in Table 1 . We used the evidence from these samples to establish temporal from these samples to establish temporal priority and direction for the association priority and direction for the association between cannabis use and schizophrenia. between cannabis use and schizophrenia. We calculated the overall risk of psychosis We calculated the overall risk of psychosis using adjusted odds ratios from all studies using adjusted odds ratios from all studies with the 'meta' command of Stata 8.0 with the 'meta' command of Stata 8.0 , which uses inverse- , which uses inversevariance weighting to calculate fixed and variance weighting to calculate fixed and random effects summary estimates (Sterne random effects summary estimates . Results across studies were , 2001). Results across studies were not significantly heterogeneous. not significantly heterogeneous.
The Swedish conscript cohort The Swedish conscript cohort For many years the only evidence that For many years the only evidence that cannabis use might predispose to later cannabis use might predispose to later psychosis came from a cohort study of psychosis came from a cohort study of Swedish conscripts who were followed up Swedish conscripts who were followed up using record-linkage techniques based on using record-linkage techniques based on in-patient admissions for psychiatric care in-patient admissions for psychiatric care (Andreasson (Andréasson et al et al, 1988) . A dose-response , 1988). A dose-response relationship was observed between cannarelationship was observed between cannabis use at conscription (age 18 years) and bis use at conscription (age 18 years) and schizophrenia diagnosis 15 years later. schizophrenia diagnosis 15 years later. Self-reported 'heavy cannabis users' (i.e. Self-reported 'heavy cannabis users' (i.e. who had used cannabis more than 50 times) who had used cannabis more than 50 times) were six times more likely than non-users were six times more likely than non-users to have been diagnosed with schizophrenia to have been diagnosed with schizophrenia 15 years later. However, more than half of 15 years later. However, more than half of these heavy users had a psychiatric diagthese heavy users had a psychiatric diagnosis other than psychosis at conscription, nosis other than psychosis at conscription, and when this confound was controlled and when this confound was controlled for the relative risk decreased to 2.3 (but for the relative risk decreased to 2.3 (but none the less remained statistically signifinone the less remained statistically significant). Very few heavy cannabis users (3%) cant). Very few heavy cannabis users (3%) went on to develop schizophrenia, suggestwent on to develop schizophrenia, suggesting that cannabis use may increase the risk ing that cannabis use may increase the risk for schizophrenia only among individuals for schizophrenia only among individuals already vulnerable to developing psychosis. already vulnerable to developing psychosis. The authors concluded that 'Cannabis The authors concluded that 'Cannabis should be viewed as an additional clue to should be viewed as an additional clue to the still elusive aetiology of schizophrenia'. the still elusive aetiology of schizophrenia'.
Consistent with the previous findings, a Consistent with the previous findings, a follow-up study of the same Swedish confollow-up study of the same Swedish conscript cohort showed that 'heavy cannabis script cohort showed that 'heavy cannabis users' by the age of 18 years were 6.7 times users' by the age of 18 years were 6.7 times more likely than non-users to be diagnosed more likely than non-users to be diagnosed with schizophrenia 27 years later (Zammit with schizophrenia 27 years later (Zammit et al et al, 2002) . This risk held when the , 2002). This risk held when the analysis was repeated on a subsample of analysis was repeated on a subsample of men who used cannabis only, as opposed men who used cannabis only, as opposed to using other drugs as well. The risk was to using other drugs as well. The risk was reduced but remained significant after reduced but remained significant after controlling for other potential confounding controlling for other potential confounding factors such as disturbed behaviour, low IQ factors such as disturbed behaviour, low IQ score, growing up in a city, cigarette score, growing up in a city, cigarette smoking and poor social integration. The smoking and poor social integration. The analysis was repeated on a subsample of analysis was repeated on a subsample of individuals who developed schizophrenia individuals who developed schizophrenia only 5 years after conscription to control only 5 years after conscription to control for the possibility that cannabis use is a for the possibility that cannabis use is a consequence of prodromal manifestations consequence of prodromal manifestations of psychosis. Findings were similar to those of psychosis. Findings were similar to those for the entire cohort. The authors for the entire cohort. The authors concluded that the findings are 'consistent concluded that the findings are 'consistent with a causal relationship between cannabis with a causal relationship between cannabis use and schizophrenia'. use and schizophrenia'. ) goes beyond the reliance on hospital discharge beyond the reliance on hospital discharge register data and examines the effect of register data and examines the effect of cannabis use on self-reported psychotic cannabis use on self-reported psychotic symptoms among the general population. symptoms among the general population. In this study, 4045 psychosis-free indiviIn this study, 4045 psychosis-free individuals and 59 who had a psychotic disorder duals and 59 who had a psychotic disorder were assessed at baseline and were adminiswere assessed at baseline and were administered follow-up assessments 1 year later tered follow-up assessments 1 year later and again 3 years after the baseline assessand again 3 years after the baseline assessment. For those subjects who reported ment. For those subjects who reported psychotic symptoms, an additional clinical psychotic symptoms, an additional clinical interview was conducted by an experienced interview was conducted by an experienced psychiatrist or psychologist (at baseline and psychiatrist or psychologist (at baseline and at 3-year follow-up). Compared with nonat 3-year follow-up). Compared with nonusers, individuals using cannabis at baseline users, individuals using cannabis at baseline were nearly three times more likely to were nearly three times more likely to manifest psychotic symptoms at followmanifest psychotic symptoms at followup. This risk remained significant after up. This risk remained significant after statistical adjustment for a range of factors, statistical adjustment for a range of factors, including ethnic group, marital status, including ethnic group, marital status, educational level, urbanicity (population educational level, urbanicity (population density) and discrimination. The authors density) and discrimination. The authors also found a dose-response relationship also found a dose-response relationship with the highest risk (odds ratio with the highest risk (odds ratio¼6.8) for 6.8) for the highest level of cannabis use. Further the highest level of cannabis use. Further analysis revealed that lifetime history of analysis revealed that lifetime history of cannabis use at baseline, as opposed to cannabis use at baseline, as opposed to use of cannabis at follow-up, was a stronger use of cannabis at follow-up, was a stronger predictor of psychosis 3 years later. This predictor of psychosis 3 years later. This suggests that the association between cansuggests that the association between cannabis use and psychosis is not merely the nabis use and psychosis is not merely the result of short-term effects of cannabis use result of short-term effects of cannabis use leading to an acute psychotic episode. leading to an acute psychotic episode. Although the use of other drugs was assoAlthough the use of other drugs was associated with psychosis outcomes, the effects ciated with psychosis outcomes, the effects were not significant after taking into acwere not significant after taking into account cannabis use. In this study, the short count cannabis use. In this study, the short time-lag between baseline and follow-up time-lag between baseline and follow-up assessments tends to provide more support assessments tends to provide more support for an association between cannabis use for an association between cannabis use and psychosis, rather than verifying temand psychosis, rather than verifying temporal priority. The authors concluded that poral priority. The authors concluded that their study confirmed that their study confirmed that 'cannabis use is an independent risk factor for 'cannabis use is an independent risk factor for the emergence of psychosis in psychosis-free the emergence of psychosis in psychosis-free persons and that those with an established persons and that those with an established vulnerability to psychotic disorders are partivulnerability to psychotic disorders are particularly sensitive to its effects, resulting in a poor cularly sensitive to its effects, resulting in a poor outcome'. outcome'. Individuals who met the diagnostic criteria for cannabis met the diagnostic criteria for cannabis dependence disorder at age 18 years had dependence disorder at age 18 years had a 3.7-fold increased risk of psychotic a 3.7-fold increased risk of psychotic symptoms than those without cannabis symptoms than those without cannabis dependence problems. The risk of psychotic dependence problems. The risk of psychotic symptoms was 2.3 times higher for those symptoms was 2.3 times higher for those with cannabis dependence disorder at age with cannabis dependence disorder at age 21 years. Moreover, after controlling for 21 years. Moreover, after controlling for several confounding factors, including several confounding factors, including anxiety disorder, deviant peer affiliations, anxiety disorder, deviant peer affiliations, exposure to childhood sexual or physical exposure to childhood sexual or physical abuse, educational achievement and, abuse, educational achievement and, most importantly, psychotic symptoms at most importantly, psychotic symptoms at the previous assessment, the association the previous assessment, the association remained strong and significant at age 21 remained strong and significant at age 21 years. The authors concluded that years. The authors concluded that 'the findings are clearly consistent with the view 'the findings are clearly consistent with the view that heavy cannabis use may make a causal that heavy cannabis use may make a causal contribution to the development of psychotic contribution to the development of psychotic symptoms since they show that, independently symptoms since they show that, independently of pre-existing psychotic symptoms and a wide of pre-existing psychotic symptoms and a wide range of social and contextual factors, young range of social and contextual factors, young people who develop cannabis dependence show people who develop cannabis dependence show an elevated rate of psychotic symptoms'. an elevated rate of psychotic symptoms'.
Dunedin Multidisciplinary Dunedin Multidisciplinary Health and Development Study Health and Development Study
The Dunedin Multidisciplinary Health and The Dunedin Multidisciplinary Health and Development Study Development Study is a study of a general-population birth cois a study of a general-population birth cohort of individuals born in Dunedin, New hort of individuals born in Dunedin, New Zealand (96% follow-up rate at age 26 Zealand (96% follow-up rate at age 26 years). Although small, this study has unique years). Although small, this study has unique advantages: it has information on selfadvantages: it has information on selfreported psychotic symptoms at age 11 reported psychotic symptoms at age 11 years, before the onset of cannabis use; it years, before the onset of cannabis use; it allows the examination of the age of onset allows the examination of the age of onset of cannabis use in relation to later outcome, of cannabis use in relation to later outcome, because self-reports of cannabis use were because self-reports of cannabis use were obtained at ages 15 and 18 years; and it obtained at ages 15 and 18 years; and it does not rely on treatment data for outdoes not rely on treatment data for outcomes because the entire cohort was assessed comes because the entire cohort was assessed at age 26 years using a standardised psyat age 26 years using a standardised psychiatric interview schedule yielding DSMchiatric interview schedule yielding DSM-IV (American Psychiatric Association, IV (American Psychiatric Association, 1994) diagnoses (Poulton 1994) diagnoses (Poulton et al et al, 2000) . This , 2000) . This allowed the examination of schizophrenia allowed the examination of schizophrenia outcome both as a continuum (by examinoutcome both as a continuum (by examination of symptoms) and as a disorder ation of symptoms) and as a disorder (DSM-IV schizophreniform disorder) in (DSM-IV schizophreniform disorder) in this population. In obtaining a schizothis population. In obtaining a schizophreniform diagnosis, the interview protophreniform diagnosis, the interview protocol ruled out psychotic symptoms col ruled out psychotic symptoms occurring while under the influence of occurring while under the influence of alcohol and drugs. alcohol and drugs.
Individuals using cannabis at ages 15 Individuals using cannabis at ages 15 and 18 years had higher rates of psychotic and 18 years had higher rates of psychotic symptoms at age 26 years compared with symptoms at age 26 years compared with non-users (Arseneault non-users (Arseneault et al et al, 2002 ). This , 2002 . This remained significant after controlling for remained significant after controlling for psychotic symptoms pre-dating the onset psychotic symptoms pre-dating the onset of cannabis use. The effect was stronger of cannabis use. The effect was stronger with earlier use. In addition, onset of canwith earlier use. In addition, onset of cannabis use by age 15 years was associated nabis use by age 15 years was associated with an increased likelihood of meeting with an increased likelihood of meeting the diagnostic criteria for schizophreniform the diagnostic criteria for schizophreniform disorder at age 26 years. Indeed, 10.3% of disorder at age 26 years. Indeed, 10.3% of cannabis users aged 15 years in this cohort cannabis users aged 15 years in this cohort were diagnosed with schizophreniform diswere diagnosed with schizophreniform disorder at age 26 years, as opposed to 3% of order at age 26 years, as opposed to 3% of the controls. After controlling for psychotic the controls. After controlling for psychotic symptoms at age 11 years, the risk for adult symptoms at age 11 years, the risk for adult schizophreniform disorder remained eleschizophreniform disorder remained elevated (odds ratio vated (odds ratio¼3.1) but was no longer 3.1) but was no longer statistically significant, possibly owing to statistically significant, possibly owing to power limitation. power limitation.
Cannabis use by age 15 years did not Cannabis use by age 15 years did not predict depressive outcomes at age 26 years predict depressive outcomes at age 26 years (indicating specificity of the outcome) and (indicating specificity of the outcome) and the use of other illicit drugs in adolescence the use of other illicit drugs in adolescence did not predict schizophrenia outcomes did not predict schizophrenia outcomes over and above the effect of cannabis use over and above the effect of cannabis use (indicating specificity of the exposure). A (indicating specificity of the exposure). A significant exacerbation (or interaction) significant exacerbation (or interaction) effect was found between cannabis use by effect was found between cannabis use by age 18 years and psychotic symptoms at age 18 years and psychotic symptoms at age 11 years (Fig. 1) . This effect indicates age 11 years (Fig. 1) . This effect indicates that cannabis users at age 18 years had elethat cannabis users at age 18 years had elevated scores on the schizophrenic symptom vated scores on the schizophrenic symptom scale only if they had reported psychotic scale only if they had reported psychotic symptoms at age 11 years. The authors symptoms at age 11 years. The authors concluded that concluded that 'using cannabis in adolescence increases the like-'using cannabis in adolescence increases the likelihood of experiencing symptoms of schizolihood of experiencing symptoms of schizophrenia in adulthood'. phrenia in adulthood'.
DISCUSSION DISCUSSION
Is cannabis a causal risk factor Is cannabis a causal risk factor for psychosis? for psychosis?
In this review we have tried to determine In this review we have tried to determine whether cannabis is a cause of schizowhether cannabis is a cause of schizophrenia. We have shown that all the phrenia. We have shown that all the available population-based studies on the available population-based studies on the issue have found that cannabis use is assoissue have found that cannabis use is associated with later schizophrenia outcomes ciated with later schizophrenia outcomes ( Table 1 ). All these studies support the (Table 1 ). All these studies support the concept of temporal priority by showing concept of temporal priority by showing that cannabis use most probably preceded that cannabis use most probably preceded schizophrenia. These studies also provide schizophrenia. These studies also provide evidence for direction by showing that the evidence for direction by showing that the association between adolescent cannabis association between adolescent cannabis use and adult psychosis persists after conuse and adult psychosis persists after controlling for many potential confounding trolling for many potential confounding variables such as disturbed behaviour, low variables such as disturbed behaviour, low IQ, place of upbringing, cigarette smoking, IQ, place of upbringing, cigarette smoking, poor social integration, gender, age, ethnic poor social integration, gender, age, ethnic group, level of education, unemployment, group, level of education, unemployment, single marital status and previous psychotic single marital status and previous psychotic 
Methodological issues Methodological issues
Before discussing further the issue of a Before discussing further the issue of a causal association between cannabis use causal association between cannabis use and schizophrenia, it is important to point and schizophrenia, it is important to point out some methodological limitations in out some methodological limitations in the literature reviewed. the literature reviewed. First, various measures of schizophrenia First, various measures of schizophrenia outcome were used in these studies: hospioutcome were used in these studies: hospital discharge, pathology level of psychosis, tal discharge, pathology level of psychosis, psychotic symptoms and schizophreniform psychotic symptoms and schizophreniform disorder. The heterogeneity of the outcome disorder. The heterogeneity of the outcome makes it difficult to draw a firm conclusion makes it difficult to draw a firm conclusion on schizophrenia on schizophrenia per se per se from the findings from the findings reported by these studies. However, all reported by these studies. However, all studies converge in showing an elevated studies converge in showing an elevated risk for psychosis in later life among risk for psychosis in later life among cannabis users. cannabis users.
Second, all measures of cannabis use in Second, all measures of cannabis use in these studies were based on self-reports and these studies were based on self-reports and were not supplemented by urine tests or were not supplemented by urine tests or hair analysis. In this situation, under-rather hair analysis. In this situation, under-rather than over-reporting is possible. Therefore, than over-reporting is possible. Therefore, the use of self-reported data would underthe use of self-reported data would underestimate the magnitude of the association estimate the magnitude of the association between cannabis use and later schizobetween cannabis use and later schizophrenia, rather than giving rise to a spurphrenia, rather than giving rise to a spurious association. In fact, in the Dunedin ious association. In fact, in the Dunedin study and the Christchurch study partistudy and the Christchurch study participants have learned after many years of cipants have learned after many years of involvement with the study that all involvement with the study that all information they provide remains strictly information they provide remains strictly confidential and therefore their answers confidential and therefore their answers are likely to provide a good estimate of acare likely to provide a good estimate of actual levels of drug use in those populations tual levels of drug use in those populations (Arseneault (Arseneault et al et al, 2002; Fergusson , 2002; Fergusson et al et al, , 2003 Fergusson et al et al, , ). 2003 .
Third, there is limited information on Third, there is limited information on other illicit drug use. It would be informaother illicit drug use. It would be informative to gather more precise information tive to gather more precise information about other illicit drugs used by young about other illicit drugs used by young people to control more effectively for posspeople to control more effectively for possible confounding effects of, for example, ible confounding effects of, for example, stimulant drug use. However, difficulties stimulant drug use. However, difficulties related to statistical power are likely to related to statistical power are likely to occur because of the small number of occur because of the small number of individuals reporting such use. individuals reporting such use.
Fourth, most studies were unable to Fourth, most studies were unable to establish whether prodromal manifestaestablish whether prodromal manifestations of schizophrenia preceded cannabis tions of schizophrenia preceded cannabis use, leaving the possibility that cannabis use, leaving the possibility that cannabis use may be a consequence of emerging use may be a consequence of emerging schizophrenia rather than a cause of it. schizophrenia rather than a cause of it. Findings have indicated that schizophrenia Findings have indicated that schizophrenia is typically preceded by psychological and is typically preceded by psychological and behavioural changes years before the onset behavioural changes years before the onset of diagnosed disease (Jones of diagnosed disease (Jones et al et al, 1994; , 1994; Cannon Cannon et al et al, 1997; Malmberg , 1997; Malmberg et al et al, , 1998) . It is possible, therefore, that canna-1998). It is possible, therefore, that cannabis use may be consequent to an early emerbis use may be consequent to an early emerging schizophrenia rather than predisposing ging schizophrenia rather than predisposing to its development. Thus, it has become to its development. Thus, it has become crucial to control for these early signs of crucial to control for these early signs of psychosis to establish clearly the temporal psychosis to establish clearly the temporal priority between cannabis use and adult priority between cannabis use and adult psychosis. Although the Christchurch study psychosis. Although the Christchurch study applied statistical control for previous applied statistical control for previous psychotic symptoms, it is not clear whether psychotic symptoms, it is not clear whether the measure of psychotic symptoms at age the measure of psychotic symptoms at age 18 years preceded the onset of cannabis 18 years preceded the onset of cannabis use. To date, the Dunedin study is the only use. To date, the Dunedin study is the only study to demonstrate temporal priority by study to demonstrate temporal priority by showing that adolescent cannabis users showing that adolescent cannabis users are at increased risk of experiencing schizoare at increased risk of experiencing schizophrenic symptoms in adult life, even after phrenic symptoms in adult life, even after taking into account the childhood psychotic taking into account the childhood psychotic symptoms that preceded the onset of symptoms that preceded the onset of cannabis use. cannabis use.
Finally, there was limited statistical Finally, there was limited statistical power in the studies using self-reports of power in the studies using self-reports of schizophrenia outcomes (in the NEMESIS, schizophrenia outcomes (in the NEMESIS, the Christchurch and the Dunedin studies) the Christchurch and the Dunedin studies) for examining such a rare outcome. It will for examining such a rare outcome. It will be important for future studies to examine be important for future studies to examine larger population samples in order to assess larger population samples in order to assess a greater number of individuals with a greater number of individuals with psychotic disorders. psychotic disorders.
Alternative explanations Alternative explanations
One might speculate that cannabis is a One might speculate that cannabis is a 'gateway drug' for the use of harder drugs 'gateway drug' for the use of harder drugs (Kazuo & Kandel, 1984) and that indivi- (Kazuo & Kandel, 1984) and that individuals who use cannabis heavily might also duals who use cannabis heavily might also be using other substances such as amphetabe using other substances such as amphetamines, phenylcyclidine and lysergic acid mines, phenylcyclidine and lysergic acid diethylamide that are diethylamide that are thought to be psychothought to be psychotogenic (Murray togenic (Murray et al et al, , 2003) . Support for 2003). Support for this explanation is provided by recent findthis explanation is provided by recent findings showing that the use of other drugs ings showing that the use of other drugs among young adults is almost always among young adults is almost always preceded by cannabis use (Fergusson & preceded by cannabis use (Fergusson & Horwood, 2000) . This is especially true Horwood, 2000) . This is especially true for heavy cannabis users for heavy cannabis users (50 times or more (50 times or more per year), who were per year), who were 140 times more likely 140 times more likely to move on to other illicit drugs than to move on to other illicit drugs than people who had not used cannabis before. people who had not used cannabis before. However, in the Dunedin, Christchurch, However, in the Dunedin, Christchurch, Dutch and Swedish studies, the association Dutch and Swedish studies, the association between cannabis and schizophrenia held between cannabis and schizophrenia held even when adjusting for the use of other even when adjusting for the use of other drugs ( A second possibility is that individuals A second possibility is that individuals who use cannabis in adolescence continue who use cannabis in adolescence continue to use this illicit substance in adulthood to use this illicit substance in adulthood and because cannabis use intoxication can and because cannabis use intoxication can be associated with transient psychotic be associated with transient psychotic symptoms (Hall & Degenhardt, 2004; symptoms (Hall & Degenhardt, 2004; Verdoux, 2004) this could account for Verdoux, 2004) this could account for the observed association. However, the the observed association. However, the diagnostic interview used in the Dunedin diagnostic interview used in the Dunedin study explicitly ruled out a diagnosis of study explicitly ruled out a diagnosis of schizophreniform disorder if psychotic schizophreniform disorder if psychotic symptoms occurred only following substance symptoms occurred only following substance use. use.
A third possibility is that early-onset A third possibility is that early-onset cannabis use is a proxy measure for poor cannabis use is a proxy measure for poor premorbid adjustment, which is known to premorbid adjustment, which is known to be associated with schizophrenia and other be associated with schizophrenia and other psychiatric outcomes (Cannon psychiatric outcomes (Cannon et al et al, 2002) . , 2002). Arseneault Arseneault et al et al (2002) found that cannabis (2002) found that cannabis use was specifically related to schizouse was specifically related to schizophrenia outcomes, as opposed to depresphrenia outcomes, as opposed to depression, suggesting specificity in longitudinal sion, suggesting specificity in longitudinal association rather than general poor preassociation rather than general poor premorbid adjustment, although there is other morbid adjustment, although there is other evidence showing an association between evidence showing an association between cannabis use and depression (Patton cannabis use and depression (Patton et al et al, , 2002 (Patton et al et al, , ). 2002 .
What kind of cause is it? What kind of cause is it?
We have shown, on the basis of the best We have shown, on the basis of the best evidence currently available, that cannabis evidence currently available, that cannabis use is likely to play a causal role with use is likely to play a causal role with regard to schizophrenia. However, further regard to schizophrenia. However, further questions now arise. How strong is the cauquestions now arise. How strong is the causal effect and is cannabis use a necessary or sal effect and is cannabis use a necessary or sufficient cause of schizophrenia (Rothman sufficient cause of schizophrenia ?
The studies reviewed earlier show that The studies reviewed earlier show that cannabis use is clearly not a necessary cause cannabis use is clearly not a necessary cause for the development of psychosis, by failing for the development of psychosis, by failing to show that all adults with schizophrenia to show that all adults with schizophrenia used cannabis in adolescence. It is also clear used cannabis in adolescence. It is also clear that cannabis use is not a sufficient cause that cannabis use is not a sufficient cause for later psychosis because the majority of for later psychosis because the majority of adolescent cannabis users did not develop adolescent cannabis users did not develop schizophrenia in adulthood. Therefore, we schizophrenia in adulthood. Therefore, we can conclude that cannabis use is a compocan conclude that cannabis use is a component cause, among possibly many others, nent cause, among possibly many others, forming part of a causal constellation that forming part of a causal constellation that leads to adult schizophrenia. leads to adult schizophrenia.
What might the other component causes be? What might the other component causes be?
Unfortunately, we get little insight on Unfortunately, we get little insight on component causes other than cannabis component causes other than cannabis from the studies reviewed in this article. from the studies reviewed in this article. Certainly, genes are likely to moderate the Certainly, genes are likely to moderate the association between cannabis use and later association between cannabis use and later psychosis by increasing the susceptibility psychosis by increasing the susceptibility of schizophrenic outcomes among earlyof schizophrenic outcomes among earlyonset cannabis users. However, no study onset cannabis users. However, no study yet has verified an interaction effect yet has verified an interaction effect between candidate genes and cannabis between candidate genes and cannabis use. Cannabis use appears to increase the use. Cannabis use appears to increase the risk of schizophrenia outcomes primarily risk of schizophrenia outcomes primarily among those individuals already vulnerable among those individuals already vulnerable by virtue of pre-existing psychotic sympby virtue of pre-existing psychotic symptoms (Arseneault toms (Arseneault et al et al, 2002; van Os , 2002; van Os et al et al, , 2002) . A study of French undergraduate 2002) . A study of French undergraduate university students showed that the acute university students showed that the acute effects of cannabis were stronger among effects of cannabis were stronger among participants with high vulnerability for participants with high vulnerability for psychosis (by virtue of psychotic symppsychosis (by virtue of psychotic symptoms) (Verdoux toms) (Verdoux et al et al, 2003) . Such vulner-, 2003) . Such vulnerable participants reported an increased able participants reported an increased level of perceived hostility and unusual level of perceived hostility and unusual perceptions, and also a decreased level of perceptions, and also a decreased level of pleasure associated with the experience of pleasure associated with the experience of using cannabis. However, this mediator using cannabis. However, this mediator effect (Kraemer effect (Kraemer et al et al, 2001) is not a simple , 2001) is not a simple one. one.
Two studies explored the role of cannaTwo studies explored the role of cannabis use in the development of psychotic bis use in the development of psychotic symptoms in groups of young people symptoms in groups of young people considered to be at high risk of developing considered to be at high risk of developing psychotic symptoms. An analysis of the psychotic symptoms. An analysis of the Edinburgh High Risk Study found that Edinburgh High Risk Study found that both individuals at high genetic risk of both individuals at high genetic risk of schizophrenia (by virtue of two affected schizophrenia (by virtue of two affected relatives) and individuals with no family relatives) and individuals with no family history of schizophrenia were at increased history of schizophrenia were at increased risk of psychotic symptoms after cannabis risk of psychotic symptoms after cannabis use (Miller use (Miller et al et al, 2001 ). An Australian , 2001 ). An Australian study followed up a group of 100 indivistudy followed up a group of 100 individuals who asked for help from an early duals who asked for help from an early intervention service centre (Phillips intervention service centre (Phillips et al et al, , 2002) . Cannabis use or dependence at entry 2002). Cannabis use or dependence at entry to the study was not associated with the to the study was not associated with the development of psychotic illness (transition development of psychotic illness (transition to psychosis) over a 12-month period of to psychosis) over a 12-month period of follow-up after entry to the study. Howfollow-up after entry to the study. However, the low level of reported cannabis ever, the low level of reported cannabis use among the group could indicate that use among the group could indicate that the sample may not be representative of the sample may not be representative of the population of 'prodromal' individuals. the population of 'prodromal' individuals.
How strong is the causal effect? How strong is the causal effect?
Can we say anything about the strength of Can we say anything about the strength of the causal effect of cannabis for schizothe causal effect of cannabis for schizophrenia? We are somewhat hampered in phrenia? We are somewhat hampered in this endeavour because the strength of any this endeavour because the strength of any particular cause depends on the prevalence particular cause depends on the prevalence of the other component or interacting of the other component or interacting causes in the population (Rothman & causes in the population . As discussed above, we Greenland, 1998). As discussed above, we do not know for certain, at present, any do not know for certain, at present, any other component causes in the 'schizoother component causes in the 'schizophrenia constellation'. We can make some phrenia constellation'. We can make some broad suggestions. A component cause, broad suggestions. A component cause, even if it is very common, will rarely cause even if it is very common, will rarely cause a disorder if the other component causes in a disorder if the other component causes in the causal constellation are rare. This will the causal constellation are rare. This will hold regardless of the prevalence of the hold regardless of the prevalence of the component cause of interest in the popucomponent cause of interest in the population or its role in the pathophysiology of lation or its role in the pathophysiology of the disorder. On the other hand, the rarer the disorder. On the other hand, the rarer a component cause relative to its partners a component cause relative to its partners in any sufficient cause, the stronger that in any sufficient cause, the stronger that component cause will appear. Because cancomponent cause will appear. Because cannabis use is relatively common in the popunabis use is relatively common in the population but appears to cause schizophrenia lation but appears to cause schizophrenia rarely, it would follow that at least one of rarely, it would follow that at least one of the other component causes in the causal the other component causes in the causal constellation is rare. Indeed, calculation of constellation is rare. Indeed, calculation of the overall risk for schizophrenia associated the overall risk for schizophrenia associated with cannabis use revealed that cannabis with cannabis use revealed that cannabis use confers only a twofold increase in use confers only a twofold increase in relative risk for schizophrenia. But does this relative risk for schizophrenia. But does this mean that we should not worry about mean that we should not worry about cannabis as a causal factor? cannabis as a causal factor?
There is another way of looking at this There is another way of looking at this issue. Once a direct causal relationship issue. Once a direct causal relationship between exposure and outcome is assumed, between exposure and outcome is assumed, the strength of a particular association from the strength of a particular association from a public health point of view can be a public health point of view can be assessed with the population attributable assessed with the population attributable fraction. This gives a measure of the fraction. This gives a measure of the number of cases of the disorder in the number of cases of the disorder in the population that could be eliminated (i.e. population that could be eliminated (i.e. would not occur) by removal of a harmful would not occur) by removal of a harmful causal factor. The population-attributable causal factor. The population-attributable fraction for the Dunedin study is 8%. In fraction for the Dunedin study is 8%. In other words, removal of cannabis use from other words, removal of cannabis use from the New Zealand population aged 15 years the New Zealand population aged 15 years would have led to an 8% reduction in the would have led to an 8% reduction in the incidence of schizophrenia in that popuincidence of schizophrenia in that population. The NEMESIS group reported lation. The NEMESIS group reported higher population-attributable fractions, higher population-attributable fractions, possibly because the outcome measures that possibly because the outcome measures that they used did not exclusively include clinithey used did not exclusively include clinical psychosis cases (i.e. the need for care). cal psychosis cases (i.e. the need for care). However, even 8% is not an insignificant However, even 8% is not an insignificant figure from a public health point of view. figure from a public health point of view. Because the possibility of eliminating Because the possibility of eliminating cannabis use totally from the population cannabis use totally from the population is rather remote, it may be advisable to is rather remote, it may be advisable to concentrate on those for whom adverse concentrate on those for whom adverse outcomes are more common (vulnerable outcomes are more common (vulnerable youths). youths).
If cannabis use can cause psychosis, If cannabis use can cause psychosis, how can we explain that, despite steadily how can we explain that, despite steadily increasing rates of cannabis use over past increasing rates of cannabis use over past decades, the incidence of schizophrenia in decades, the incidence of schizophrenia in the population has remained stable? First, the population has remained stable? First, with a population-attributable fraction of with a population-attributable fraction of 8% the causal influence of cannabis use 8% the causal influence of cannabis use on the incidence of schizophrenia is on the incidence of schizophrenia is probably not easily visible in the general probably not easily visible in the general population. Second, the Dunedin study population. Second, the Dunedin study showed that cannabis use in early adolesshowed that cannabis use in early adolescence (first reported use at age 15 years) cence (first reported use at age 15 years) was associated with the strongest effects was associated with the strongest effects on schizophrenia outcomes. Trends of on schizophrenia outcomes. Trends of cannabis use among adolescents in the cannabis use among adolescents in the USA indicate that cannabis use under the USA indicate that cannabis use under the age of 16 years is a fairly new phenomenon age of 16 years is a fairly new phenomenon that has appeared only since the early that has appeared only since the early 1990s (Johnston 1990s (Johnston et al et al, 2002) . One would , 2002). One would therefore predict an increase in rates of therefore predict an increase in rates of schizophrenia in the general population schizophrenia in the general population over the next 10 years. Indeed, there is over the next 10 years. Indeed, there is already some evidence that the incidence already some evidence that the incidence of schizophrenia is currently increasing in of schizophrenia is currently increasing in some areas of London, especially among some areas of London, especially among young people (Boydell young people (Boydell et al et al, 2003) . , 2003 Cannabis use in adolescence leads to a two-to threefold increase in relative risk for schizophrenia or schizophreniform disorder in adulthood. The earlier the age of schizophrenia or schizophreniform disorder in adulthood. The earlier the age of onset of cannabis use, the greater the risk for psychotic outcomes. onset of cannabis use, the greater the risk for psychotic outcomes. A minority of individuals experience harmful outcome consequent to their use of cannabis. However, this minority is significant both from a clinical point of view and at cannabis. However, this minority is significant both from a clinical point of view and at a population level. It is estimated that about 8% of schizophrenia could be prevented a population level. It is estimated that about 8% of schizophrenia could be prevented by elimination of cannabis use in the population. by elimination of cannabis use in the population. 
